A61P3/02

HYDROLYZED COMPOUND PROTEIN FOR LARVAL LARGEMOUTH BASS (MICROPTERUS SALMOIDES) AND USE THEREOF

A hydrolysate compound protein for larval largemouth bass (Micropterus salmoides) and use thereof for aquatic animal feeds. The micro-diet was formulated with the following components: 72-74 parts by weight of a hydrolyzed protein pre-mixture, 3-5 parts by weight of mixed fish soluble meal, 4-6 parts by weight of gluten flour, 2-4 parts by weight of sodium caseinate, and 0.4-0.6 parts by weight of a yeast hydrolysate, where the hydrolyzed protein pre-mixture includes white fish meal, fermented soybean meal, shrimp meal and blood meal with the weight ratio of 58-62: 5-7: 4-6: 2-3. The compound protein is obtained by fully pulverizing the foregoing components, passing through a 100-mesh sieve, fully mixing in proportion, and being hydrolyzed with neutral protease and keratinase.

HYDROLYZED COMPOUND PROTEIN FOR LARVAL LARGEMOUTH BASS (MICROPTERUS SALMOIDES) AND USE THEREOF

A hydrolysate compound protein for larval largemouth bass (Micropterus salmoides) and use thereof for aquatic animal feeds. The micro-diet was formulated with the following components: 72-74 parts by weight of a hydrolyzed protein pre-mixture, 3-5 parts by weight of mixed fish soluble meal, 4-6 parts by weight of gluten flour, 2-4 parts by weight of sodium caseinate, and 0.4-0.6 parts by weight of a yeast hydrolysate, where the hydrolyzed protein pre-mixture includes white fish meal, fermented soybean meal, shrimp meal and blood meal with the weight ratio of 58-62: 5-7: 4-6: 2-3. The compound protein is obtained by fully pulverizing the foregoing components, passing through a 100-mesh sieve, fully mixing in proportion, and being hydrolyzed with neutral protease and keratinase.

Crosslinked UV Absorbing Complex Polyol Polyester Polymers
20170355813 · 2017-12-14 ·

The invention includes an UV absorbing complex polyol polyester polymer that is the product of a reaction scheme that includes: (i) the esterification of a polyol and a dianhydride, wherein the esterification is carried out under conditions that facilitate substantially only anhydride opening, to form a polyester polymer comprising at least two pendant carboxylic groups, and at least two hydroxyl groups; and (ii) the reaction of at least one pendant carboxylic group and at least one terminal hydroxyl group of the polyester polymer with an epoxide having a functional group, wherein the epoxide comprises an UV absorbing moiety.

Also included are linear UV absorbing complex polyol polyester polymers represented by Formula (XI):

##STR00001##

wherein R.sup.3 is independently selected from an UV absorbing moiety; R.sup.4 and R.sup.5 are each independently selected from a hydrocarbon group, and n is an integer of 1 to 1000.

A crosslinked UV absorbing complex polyol polyester polymer that is reaction product of a random copolyesterification esterification reaction and/or the esterification product of: a monofunctional carboxylic acid and/or ester that comprises an UV absorbing moiety, at least one of a diol, a polyol, a diacid and/or an ester is also included within the scope of the invention. The resulting polymer has an UV absorbing functionality of greater than 2.0.

KRILL OIL PREPARATIONS WITH OPTIMAL MINERAL AND METAL COMPOSITION, LOW IMPURITIES AND LOW AND STABLE TMA LEVELS
20170354694 · 2017-12-14 ·

A Krill oil preparation including a reduced amount of trimethylamine of 5 mgN/100 g or less, or more than 700 ppm by weight of endogenous calcium and/or less than 1200 ppm by weight of sodium. A process of making such a Krill oil preparation that includes a step of extracting Krill oil from Krill with a solvent mixture of one or more polar solvents and one or more non-polar solvents. A method of treating a human in need of treatment that includes administering to the human an amount of such a Krill oil preparation.

COMPOSITION FOR DECREASING HEMATOPOIETIC STEM CELLS, AND METHOD FOR PRODUCING SAME

Problem to be Solved

The present invention provides a technique replacing radiation exposure in decreasing or eliminating hematopoietic stem cells in an animal (particularly human) body.

Solution A parenteral nutrition formula or an enteral nutrition formula substantially free of valine.

EXTERNAL COMPOSITION FOR SCREEN FOAMERS

The present invention addresses the issue of providing an external composition for screen foamers such as pump foamers, that can be safely used even when not removed after application. Provided is an external composition for screen foamers, including a non-ionic surfactant as a foaming component and, ideally, being in a soluble state.

IRON COMPLEXES OF ESTERIFIED DERIVATIVES OF NATURAL PRODUCTS, AND METHODS OF USE
20230190937 · 2023-06-22 ·

Consumable (edible) iron-containing compositions containing precisely or at least the following components: (i) an edible oil; (ii) ionic iron, typically as an iron salt or iron complex; and (iii) an esterified derivative of a natural product, such as an esterified version of curcumin, catechin, or ascorbic acid. Methods for preparing these compositions are also disclosed. Food products containing these compositions are also disclosed. Also disclosed herein are methods for treating a subject having an iron deficiency by administering the iron-containing composition to the subject.

IRON COMPLEXES OF ESTERIFIED DERIVATIVES OF NATURAL PRODUCTS, AND METHODS OF USE
20230190937 · 2023-06-22 ·

Consumable (edible) iron-containing compositions containing precisely or at least the following components: (i) an edible oil; (ii) ionic iron, typically as an iron salt or iron complex; and (iii) an esterified derivative of a natural product, such as an esterified version of curcumin, catechin, or ascorbic acid. Methods for preparing these compositions are also disclosed. Food products containing these compositions are also disclosed. Also disclosed herein are methods for treating a subject having an iron deficiency by administering the iron-containing composition to the subject.

LIPASE FORMULATIONS AND METHODS THEREOF
20230193228 · 2023-06-22 ·

Disclosed are compositions and formulations of lipase and methods of treatment and manufacture thereof.

LIPASE FORMULATIONS AND METHODS THEREOF
20230193228 · 2023-06-22 ·

Disclosed are compositions and formulations of lipase and methods of treatment and manufacture thereof.